推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 12月7日，隆基發(fā)布公告，簽訂曲靖靖年產(chǎn)10GW單晶硅棒和硅片建設(shè)項(xiàng)目投資協(xié)議，該項(xiàng)目投資金額為34億，預(yù)計(jì)2021年投產(chǎn)。
這已經(jīng)是近幾個(gè)月來(lái)隆基第七次大規(guī)模擴(kuò)產(chǎn)。
對(duì)于隆基的不停擴(kuò)產(chǎn)，業(yè)內(nèi)人士表示早已習(xí)慣，只是本期公告中，特別指出了風(fēng)險(xiǎn)提示：1、項(xiàng)目實(shí)施前尚需履行公司內(nèi)部審議程序。2、如因國(guó)家或地方有關(guān)政策調(diào)整、項(xiàng)目審批等實(shí)施條件及融資環(huán)境發(fā)生變化，項(xiàng)目的實(shí)施可能存在順延、變更、中止或終止的風(fēng)險(xiǎn)。3、鑒于上述項(xiàng)目投資建設(shè)可能會(huì)對(duì)公司現(xiàn)金流造成壓力，公司將統(tǒng)籌資金安排，確保項(xiàng)目順利實(shí)施。
換句話說(shuō)，該項(xiàng)目最終是否落地，還存在著大量變數(shù)，項(xiàng)目本身還沒(méi)有經(jīng)過(guò)公司的內(nèi)部審議，公告中隆基保留了大量的余地。
